Arcadia Investment Management Corp MI Purchases Shares of 267 HealthEquity, Inc. (NASDAQ:HQY)

Arcadia Investment Management Corp MI acquired a new stake in shares of HealthEquity, Inc. (NASDAQ:HQY) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 267 shares of the company’s stock, valued at approximately $26,000.

Several other institutional investors and hedge funds also recently made changes to their positions in HQY. UMB Bank n.a. boosted its holdings in shares of HealthEquity by 65.6% in the 4th quarter. UMB Bank n.a. now owns 414 shares of the company’s stock worth $40,000 after acquiring an additional 164 shares in the last quarter. Quarry LP raised its position in HealthEquity by 418.8% in the 3rd quarter. Quarry LP now owns 1,349 shares of the company’s stock valued at $110,000 after purchasing an additional 1,089 shares during the last quarter. 1620 Investment Advisors Inc. acquired a new position in HealthEquity in the third quarter worth $112,000. GAMMA Investing LLC grew its holdings in shares of HealthEquity by 32.9% during the fourth quarter. GAMMA Investing LLC now owns 1,248 shares of the company’s stock worth $120,000 after purchasing an additional 309 shares during the last quarter. Finally, Covestor Ltd increased its stake in shares of HealthEquity by 27.4% in the third quarter. Covestor Ltd now owns 1,524 shares of the company’s stock valued at $125,000 after buying an additional 328 shares in the last quarter. Institutional investors and hedge funds own 99.55% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on HQY shares. Mizuho assumed coverage on shares of HealthEquity in a report on Wednesday, December 4th. They set an “outperform” rating and a $126.00 price objective on the stock. Barrington Research upped their target price on shares of HealthEquity from $105.00 to $120.00 and gave the stock an “outperform” rating in a research report on Monday, December 2nd. The Goldman Sachs Group began coverage on shares of HealthEquity in a report on Friday, November 15th. They issued a “neutral” rating and a $108.00 price target for the company. Bank of America upped their price objective on HealthEquity from $100.00 to $120.00 and gave the stock a “buy” rating in a report on Wednesday, November 13th. Finally, BTIG Research lifted their target price on HealthEquity from $110.00 to $130.00 and gave the company a “buy” rating in a research note on Thursday, November 14th. One analyst has rated the stock with a hold rating and thirteen have given a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $110.71.

Insider Activity

In other HealthEquity news, Director Stuart B. Parker sold 25,000 shares of HealthEquity stock in a transaction that occurred on Thursday, December 12th. The shares were sold at an average price of $96.72, for a total value of $2,418,000.00. Following the transaction, the director now owns 19,061 shares of the company’s stock, valued at approximately $1,843,579.92. The trade was a 56.74 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Robert W. Selander sold 8,250 shares of the stock in a transaction on Monday, December 9th. The stock was sold at an average price of $101.56, for a total transaction of $837,870.00. Following the sale, the director now directly owns 66,469 shares of the company’s stock, valued at $6,750,591.64. This represents a 11.04 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 39,000 shares of company stock valued at $3,895,788 in the last quarter. Company insiders own 2.20% of the company’s stock.

HealthEquity Price Performance

Shares of HQY opened at $108.60 on Friday. The stock has a market cap of $9.41 billion, a P/E ratio of 99.63, a price-to-earnings-growth ratio of 1.63 and a beta of 0.55. HealthEquity, Inc. has a 1 year low of $65.01 and a 1 year high of $115.59. The stock’s 50-day moving average price is $103.66 and its two-hundred day moving average price is $92.05. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings data on Monday, December 9th. The company reported $0.59 earnings per share for the quarter, missing the consensus estimate of $0.71 by ($0.12). HealthEquity had a return on equity of 9.70% and a net margin of 8.41%. During the same quarter in the prior year, the business posted $0.40 EPS. On average, equities analysts predict that HealthEquity, Inc. will post 2.32 earnings per share for the current year.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.